Comparateur d'entreprises

À propos

AbbVie is a global biopharmaceutical company that was spun off from Abbott Laboratories in 2013. While Humira was once the world's best-selling drug, AbbVie has successfully navigated its patent cliff with Skyrizi and Rinvoq, which are on track to exceed Humira's peak revenue combined.

Revenus

$56.3B

Signal d'écart de nouvelles

Aucune donnée d'écart de nouvelles pour ce ticker.

Signaux institutionnels

Modèles en cascade

Non présent dans les modèles de cascade suivis.

Relations clés

À propos

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Revenus

$130.5B

Signal d'écart de nouvelles

Signaux institutionnels

Modèles en cascade

Relations clés